NCT04131803View on ClinicalTrials.gov

Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

November 25, 2022

Study Completion Date

November 25, 2025

Conditions
Unresectable Metastatic Colorectal Cancer
Interventions
DRUG

Bifico combined with chemotherapy plus targeted therapy

Bifico combined with chemotherapy plus targeted therapy

DRUG

chemotherapy plus targeted therapy

chemotherapy plus targeted therapy

All Listed Sponsors
collaborator

Zhejiang University

OTHER

collaborator

Cancer Hospital of The University of Chinese Academy of Sciences

UNKNOWN

collaborator

Hebei Medical University Fourth Hospital

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER